Prevalencia de factor V Leiden, protrombina 20210 A y homozigosis de la MTHFR: a propósito de un estudio en el Departamento de Salud n.o 19 de la Comunidad Valenciana
Clinical comments on genetic marker prevalence (factor V Leiden, prothrombin 20210A and homozygous methylenetetrahydrofolate reductase form [Ho-MTHFR]): based on a study conducted in Health Department no. 19 of the Valencian Community
Leído
673
Vecesse ha leído el artículo
672
Total PDF
1
Total HTML
Información del artículo
ISSN: 00142565Idioma original: Español
DOI:10.1157/13098497
Datos actualizados diariamente
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 0 | 9 | 9 |
| 2025 5 | 0 | 38 | 38 |
| 2025 4 | 0 | 26 | 26 |
| 2025 3 | 0 | 33 | 33 |
| 2025 2 | 0 | 31 | 31 |
| 2025 1 | 0 | 31 | 31 |
| 2024 12 | 0 | 18 | 18 |
| 2024 11 | 0 | 25 | 25 |
| 2024 10 | 1 | 36 | 37 |
| 2024 9 | 0 | 38 | 38 |
| 2024 8 | 0 | 21 | 21 |
| 2024 7 | 0 | 27 | 27 |
| 2024 6 | 0 | 20 | 20 |
| 2024 5 | 0 | 25 | 25 |
| 2024 4 | 0 | 20 | 20 |
| 2024 3 | 0 | 30 | 30 |
| 2024 2 | 0 | 28 | 28 |
| 2024 1 | 0 | 24 | 24 |
| 2023 12 | 0 | 20 | 20 |
| 2023 11 | 0 | 33 | 33 |
| 2023 10 | 0 | 40 | 40 |
| 2023 9 | 0 | 27 | 27 |
| 2023 8 | 0 | 23 | 23 |
| 2023 7 | 0 | 28 | 28 |
| 2023 6 | 0 | 18 | 18 |
| 2023 5 | 0 | 3 | 3 |
Mostrar todo
